SIGA

SIGA Technologies Inc

Halal Rating :
Comfortable
Last Price $6.22 Last updated:
Market Cap $444.49m
7D Change 2.64%
1 Year Change 21.72%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange Nasdaq
Next Earnings Date

SIGA Technologies Inc is a pharmaceutical company that develops and commercializes solutions for serious unmet medical needs and biothreats. The company's lead product is TPOXX (tecovirimat), an antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is also being developed for other orthopoxvirus infections.

The company's primary business model involves developing and selling medical countermeasures to protect against biowarfare or bioterror attacks. Their main customer is the U.S. government, particularly through contracts with agencies like BARDA (Biomedical Advanced Research and Development Authority).

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $10.01m $9.47m - - 0.00% 0.00%
June 30, 2024 $21.81m $20.73m - - 0.00% 0.00%
March 31, 2024 $25.43m $14.15m - - 0.00% 0.00%

Company Impact

Help us evaluate SIGA Technologies Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Recent News & Updates